Skip to content

3M™ Cavilon™ 5050 (UDI 10707387810693)Recalls & reported problems

3m Company · 3M™ Cavilon™ Advanced Skin Protectant 5050, 20 EA/Case · Class 1

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10707387810693), received between Sep 19, 2025 and Sep 19, 2025 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Fungal Infection1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjurySep 19, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A CUSTOMER USED 3M¿ CAVILON¿ ADVANCED SKIN PROTECTANT WITH HER OSTOMY BAG AND EXPERIENCED ITCHY AND BRIGHT PINK SKIN. ADDITIONAL INFORMATION WAS RECEIVED FROM THE CUSTOMER ON (B)(6) 2025 INDICATING A YEAST INFECTION DEVELOPED AND TREATMENT WAS INITIATED WITH TOPICAL NYSTATIN. CHANGES WERE MADE TO THE OSTOMY WAFER APPLICATION PROCESS WITH THE HELP OF A WOUND, OSTOMY AND CONTINENCE NURSE (WOCN), AND THE SYMPTOMS IMPROVED.

    Patient problems: Fungal Infection

    MAUDE report 23095829 ↗

Other Bandage, liquid devices

All Bandage, liquid devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.